The PRISMAP Radiolanthanides Workshop took place at the Paul Scherrer Institute in Switzerland from September 3 to 5, 2024. This influential three-day event gathered leading experts to review the latest advancements in radiolanthanides—radioactive elements at the forefront of cancer therapy. The workshop showcased cutting-edge developments in radiolanthanide production and explored their applications in both preclinical and clinical settings. A key highlight was an insightful panel discussion on the "Clinical Translation of Terbium-161 and Lessons Learned," which provided valuable takeaways for the future of cancer treatment. The event received extensive media coverage and was recently featured by the Swiss Society of Radiopharmacy and Radiopharmaceutical Chemistry (SGRRC) link.